Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma – Pooled analysis of two randomized trials

诱导化疗 医学 超重 内科学 体重不足 鼻咽癌 体质指数 析因分析 化疗 放化疗 随机对照试验 肿瘤科 外科 放射治疗
作者
Xu Liu,Wen‐Fei Li,Cong Ding,Lei Chen,Ying Sun,Jinghua Li,Jun Ma,Yuan Zhang
出处
期刊:Oral Oncology [Elsevier BV]
卷期号:125: 105718-105718 被引量:1
标识
DOI:10.1016/j.oraloncology.2022.105718
摘要

Induction chemotherapy followed by concurrent chemoradiotherapy is the standard of care for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). However, survival benefits from additional induction chemotherapy varied significantly among patients. This study aimed to determine the predictive value of body mass index (BMI) in induction chemotherapy in NPC.This post-hoc analysis included patients from two multicenter, randomized, phase 3 trials (NCT01245959 and NCT01872962), in which patients were randomized to receive induction chemotherapy plus concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.Among 960 patients participated, 957 were included in this analysis. 82 (8.6%) patients had baseline BMI < 18.5 kg/m2 (underweight) and 875 (91.4%) had BMI ≥ 18.5 kg/m2 (normal /overweight). Higher proportion of normal/overweight patients completed ≥2 cycles of induction chemotherapy than underweight patients (96.5% vs. 88.4%, p = 0.042). A strong trend for interaction was observed between BMI and induction chemotherapy regarding failure-free survival (FFS) and overall survival (OS, both pinteraction < 0.001). Normal/overweight patients benefited from induction chemotherapy regarding FFS (83.8% vs. 72.9%, p < 0.001) or OS (93.1% vs. 86.9%, p < 0.001), while underweight patients did not (p = 0.24 and p = 0.65, respectively). These results were confirmed in multivariate analysis and multiple sensitivity analyses.Using pooled data from two landmark phase III trials, we found that underweight patients might not benefit from additional induction chemotherapy in locoregionally advanced NPC. If confirmed in prospective studies, this could help guide individual treatment in the clinic.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
maying0318发布了新的文献求助10
1秒前
宣以晴完成签到,获得积分10
1秒前
Nnn完成签到,获得积分10
2秒前
baby完成签到,获得积分10
5秒前
123完成签到,获得积分10
5秒前
6秒前
学术牛马完成签到,获得积分10
6秒前
sl发布了新的文献求助10
8秒前
完美的鹤完成签到,获得积分10
9秒前
hky完成签到,获得积分10
10秒前
TTTHANKS完成签到 ,获得积分10
11秒前
WW完成签到,获得积分10
11秒前
LL完成签到,获得积分10
12秒前
量子星尘发布了新的文献求助10
12秒前
小马的可爱老婆2完成签到,获得积分10
12秒前
缥缈纲完成签到,获得积分10
13秒前
TY完成签到 ,获得积分10
13秒前
迷路的小蚂蚁完成签到,获得积分10
14秒前
哈儿的跟班完成签到,获得积分10
14秒前
醉熏的鑫完成签到,获得积分20
15秒前
远_09完成签到 ,获得积分10
16秒前
网站技术人员完成签到,获得积分10
17秒前
eazin完成签到 ,获得积分10
18秒前
山野桃饼完成签到,获得积分10
18秒前
无私代芹完成签到,获得积分10
19秒前
画风湖湘卷完成签到,获得积分10
19秒前
段一帆完成签到,获得积分10
20秒前
结实的老虎完成签到,获得积分10
20秒前
20秒前
邓希静完成签到,获得积分10
21秒前
24秒前
25秒前
25秒前
27秒前
是冬天完成签到,获得积分10
28秒前
mengwensi完成签到,获得积分10
28秒前
单纯血茗发布了新的文献求助10
28秒前
胡大嘴先生完成签到,获得积分10
28秒前
林钟望完成签到,获得积分10
28秒前
碧蓝碧凡发布了新的文献求助10
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038426
求助须知:如何正确求助?哪些是违规求助? 3576119
关于积分的说明 11374556
捐赠科研通 3305834
什么是DOI,文献DOI怎么找? 1819339
邀请新用户注册赠送积分活动 892678
科研通“疑难数据库(出版商)”最低求助积分说明 815029